Richard C Semelka
Overview
Explore the profile of Richard C Semelka including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
210
Citations
2100
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ramalho J, Ramalho M, Semelka R
Invest Radiol
. 2024 Dec;
PMID: 39637356
Purpose: This study documents the gadolinium (Gd) content in urine over time after the administration of a single dose of Gd-based contrast agent (GBCA) in patients diagnosed with Gd deposition...
2.
Semelka R, Ramalho M
Front Toxicol
. 2024 Aug;
6:1371131.
PMID: 39118832
Purpose: To demonstrate and evaluate factors contributing to near-cures in patients with Gadolinium Deposition Disease (GDD) undergoing intravenous (IV) DTPA chelation. Methods: Patients who had undergone or are currently undergoing...
3.
Semelka R, Ramalho M
Invest Radiol
. 2023 Apr;
58(8):523-529.
PMID: 37058336
This review describes the current knowledge of a form of gadolinium toxicity termed gadolinium deposition disease (GDD), supplemented with the opinions of the authors developed during 6 years of clinical...
4.
Semelka R, Ramalho M
Invest Radiol
. 2022 Jun;
57(10):674-676.
PMID: 35703449
No abstract available.
5.
Semelka R, Castro Pereira J, Ramalho M
Invest Radiol
. 2021 Dec;
57(5):293-300.
PMID: 34935653
Purpose: The aim of this study was to report early clinical experience with various forms of immune dampening to mitigate the expected flare reaction in patients suffering from gadolinium deposition...
6.
Semelka R, Ramalho M
Radiol Bras
. 2021 Aug;
54(4):238-242.
PMID: 34393290
Objective: The objective of this study was to allow physicians with self-diagnosed gadolinium deposition disease symptoms to report their own experience. Materials And Methods: Nine physicians (seven females), with a...
7.
Maecker H, Siebert J, Rosenberg-Hasson Y, Koran L, Ramalho M, Semelka R
Invest Radiol
. 2021 Jun;
57(1):71-76.
PMID: 34120127
Purpose: The aim of this study was to investigate the feasibility of measuring early changes in serum cytokine levels after intravenous diethylenetriaminepentaacetic acid (Ca-DTPA) chelation in patients manifesting either gadolinium...
8.
Maecker H, Siebert J, Rosenberg-Hasson Y, Koran L, Ramalho M, Semelka R
Invest Radiol
. 2021 Jan;
56(6):374-384.
PMID: 33449576
Objectives: The aim of this study was to determine the following in patients who have undergone magnetic resonance imaging with gadolinium-based contrast agents (GBCAs) and meet the proposed diagnostic criteria...
9.
Maecker H, Wang W, Rosenberg-Hasson Y, Semelka R, Hickey J, Koran L
Radiol Bras
. 2020 Oct;
53(5):306-313.
PMID: 33071374
Objective: To determine whether individuals with proposed gadolinium deposition disease (GDD) have elevated serum levels of pro-inflammatory and pro-fibrotic cytokines, and whether specific cytokines are correlated with certain symptoms. Materials...
10.
Mervak B, Altun E, McGinty K, Hyslop W, Semelka R, Burke L
J Magn Reson Imaging
. 2019 Feb;
49(3):621-631.
PMID: 30701610
There is a constantly evolving knowledgebase regarding the safety of MRI in pregnant patients, as well as the safety of gadolinium administration, given potential fetal risks. This review provides an...